GABAAreceptor deficits predict recovery in patients with disorders of consciousness: A preliminary multimodal [11C]Flumazenil PET and fMRI study-Reference-Cited by-同舟云学术

GABAAreceptor deficits predict recovery in patients with disorders of consciousness: A preliminary multimodal [11C]Flumazenil PET and fMRI study

Published:2015-07-03 Issue:10 Volume:36 Page:3867-3877
ISSN:1065-9471
Container-title:Human Brain Mapping
language:en
Short-container-title:Hum. Brain Mapp.

Author:

Qin Pengmin¹²³,Wu Xuehai⁴,Duncan Niall W.¹²³⁵,Bao Weiqi⁶,Tang Weijun⁷,Zhang Zhengwei⁶,Hu Jin⁴,Jin Yi⁴,Wu Xing⁴,Gao Liang⁴,Lu Lu⁸,Guan Yihui⁶,Lane Timothy²³,Huang Zirui²,Bodien Yelena G.⁹,Giacino Joseph T.⁹,Mao Ying⁴,Northoff Georg¹²³⁵¹⁰

Affiliation:

1. Graduate Institute of Humanities in Medicine, Taipei Medical University; Taipei Taiwan

2. Institute of Mental Health Research, University of Ottawa; Ottawa Canada

3. Brain and Consciousness Research Centre; Taipei Medical University-Shuang Ho Hospital; New Taipei City Taiwan

4. Neurosurgery Department; Huashan Hospital, Fudan University; Shanghai China

5. Centre for Cognition and Brain Disorders (CCBD); Hangzhou Normal University; Hangzhou China

6. PET/CT Centre; Huashan Hospital, Fudan University; Shanghai China

7. Radiologic Department of Huashan Hospital, Fudan University; Shanghai China

8. Antai Hospital; Shanghai China

9. Spaulding Rehabilitation Hospital; Charlestown Massachusetts

10. Research Centre for Mind, Brain and Learning; National Chengchi University; Taipei Taiwan

Funder

CIHR, HDRF, EJLB-CIHR, and the Michael Smith Foundation

National Science Foundation of China

The National Science Foundation for Distinguished Young Scholars of China

Publisher

Wiley

Subject

Neurology (clinical),Neurology,Radiology, Nuclear Medicine and imaging,Radiological and Ultrasound Technology,Anatomy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hbm.22883/fullpdf

Reference46 articles.

1. Clinical and imaging evidence of zolpidem effect in hypoxic encephalopathy;Brefel-Courbon;Ann Neurol,2007

2. Changes in cerebral metabolism in patients with a minimally conscious state responding to zolpidem;Chatelle;Front Hum Neurosci,2014

3. Pharmacotherapy for disorders of consciousness: Are ‘awakening’ drugs really a possibility?;Ciurleo;Drugs,2013

4. Neurotransmitters in coma, vegetative and minimally conscious states, pharmacological interventions;Clauss;Med Hypotheses,2010

5. Neurotransmitters in disorders of consciousness and brain damage;Clauss;Med Hypotheses,2011

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuroimaging biomarkers for the diagnosis and prognosis of patients with disorders of consciousness;Brain Research;2024-11

2. Predicting outcome in disorders of consciousness: A mega‐analysis;Annals of Clinical and Translational Neurology;2024-04-09

3. Molecular imaging for neurological diseases;Transpathology;2024

4. Multimodal approaches supporting the diagnosis, prognosis and investigation of neural correlates of disorders of consciousness: A systematic review;European Journal of Neuroscience;2023-12-23

5. Clinical application of neuromodulation therapy in patients with disorder of consciousness: A pooled analysis of 544 participants;NeuroRehabilitation;2023-12-22